Latest AI and machine learning research in oncology/hematology for healthcare professionals.
Malignant and premalignant ocular surface tumors (OSTs) can be sight-threatening or even life-threatening if not diagnosed and treated promptly. Artificial intelligence holds great promise for the early detection of these diseases. However, training traditional convolutional neural networks (CNNs) for this task presents challenges due to the lack of large, well-annotated datasets containing OST im...
Breast cancer is the leading cause of cancer-related mortality among women worldwide. The development of predictive biomarkers and immunologic markers has revolutionized breast cancer diagnosis and treatment, enabling personalized medicine approaches. This study aims to review the current status, challenges, and future directions of predictive and immunologic biomarkers in breast cancer. Predictiv...
Soft tissue sarcomas (STS) imposes a substantial healthcare burden on society. The progression of these tumors is significantly influenced by diverse ...
Breast cancer poses a real and immense threat to humankind, thus a need to develop a way of diagnosing this devastating disease early, accurately, and...
BACKGROUND: The global burden of digestive system tumors (e.g., hepatocellular carcinoma, gastric cancer, colorectal cancer) continues to rise, with l...
: The predictive value of muscle-related indicators in triple-negative breast cancer (TNBC) patients undergoing neoadjuvant chemotherapy (NAC) remains...
This study is aimed to develop predictive models for classifying thymic epithelial tumor (TET) histological subtypes (A/AB/B1, B2/B3, C) and WHO stage...
Extrachromosomal circular DNA (eccDNA) has emerged as a dynamic and versatile genomic element with key roles in physiological regulation and disease p...
PURPOSE: Accurate differentiation of the histologic invasiveness of early-stage lung adenocarcinoma is crucial for determining surgical strategies. Th...
Primary lymphoma of bone (PLB) is a rare extranodal lymphoma, and its epidemiology and prognosis remain controversial. We conducted a retrospective an...
BACKGROUND: Hepatocellular carcinoma (HCC) exhibits pronounced heterogeneity, which significantly limits the effectiveness of precision therapies. A c...
BACKGROUND: Pancreatic cancer is a highly aggressive cancer characterized by low survival rate. Enhanced ribosome biogenesis may be associated with tu...
Skin cancer is one of the most prevalent malignant tumors, and early detection is crucial for patient prognosis, leading to the development of mobile ...
BACKGROUND: National guidelines (GLs) for surgical cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of peri...
Clear cell renal carcinoma (ccRCC) is the most prevalent and aggressive subtype of kidney cancer. Targeting ccRCC metabolism is a promising therapeuti...
The treatment outcomes of lung cancer are highly variable, and machine learning (ML) models provide valuable insights into how clinical and biochemica...
Glioblastoma is the most common and aggressive malignant adult tumor of the central nervous system, with a grim prognosis and heterogeneous morphologi...
INTRODUCTION: Breast cancer is the most prevalent cancer among women, with growing incidence and mortality rates. Regardless of remarkable progress in...
The role of artificial intelligence (AI) in cancer drug discovery and development has garnered significant attention due to its potential to transform...